We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Protagen AG Collaborates with UCSF to Study Better Immuno-Profiling of Cancer Patients Receiving Immunotherapy

News   May 09, 2018 | Original story from Protagen

 
Protagen AG Collaborates with UCSF to Study Better Immuno-Profiling of Cancer Patients Receiving Immunotherapy

Immuno-oncology: Response prediction

 
 
 

RELATED ARTICLES

A New Weapon in the Fight Against Lethal Fungi

News

Researchers have discovered how nanoparticles could be used to develop a biosensor to prevent deadly diseases contracted on medical equipment.

READ MORE

A Tailored Cancer Therapy Based on HLA Gene Profile?

News

Researchers have discovered that patients with a wide variety of HLA molecules may derive more benefit from a specific type of cancer therapy.

READ MORE

Progress on Vaccines Against Four Types of Hemorrhagic Fever Viruses

News

Scientists have developed a new vaccine that protected monkeys against four types of hemorrhagic fever viruses endemic to regions in Africa.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE